Recently there has been considerable interest in a novel surrogate marker of endothelial injury, endothelial microparticles (EMP), in a number of diseases characterised by endothelial injury. This review examines the data relating to EMP in human disease states, and examines the potential for EMP to provide a window onto the activated endothelium in primary systemic vasculitides. The utility of EMP for the diagnosis and monitoring of active vasculitis is discussed.
No takes yet. Share an insight, caveat, or question.
Brogan et al. (2004) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: